Health
AstraZeneca vaccine and Guillain-Barré syndrome: There’s minimal cause for concern – Medical Xpress
The Therapeutic Goods Administration (TGA) yesterday revealed there have been six reports of Guillain-Barré syndrome in Australia following the AstraZeneca COVID…
The Therapeutic Goods Administration (TGA) yesterday revealed there have been six reports of Guillain-Barré syndrome in Australia following the AstraZeneca COVID vaccine.
This is an autoimmune disorder, which causes muscle weakness, numbness and tingling. It can be life threatening if it involves the respiratory muscles.
But at this stage, there isn’t cause for serious concern. The six reports are out of 1.8 million doses of the AstraZeneca vaccine administered in Australia so far. This means the…
Continue Reading
